Moreover, abnormalities in EGFR activation in the context of chronic diseases such as cancer or IBD may not only simply be due to altered expression of EGFR or its ligands but also be related to altered expression or activation of NOX enzymes that regulate this signaling pathway [41]. This evidence concerns the gene EGFR and inflammatory bowel disease.